Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Clearpoint Neuro Inc (CLPT)

Clearpoint Neuro Inc (CLPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 144,012
  • Shares Outstanding, K 27,070
  • Annual Sales, $ 23,960 K
  • Annual Income, $ -22,090 K
  • 60-Month Beta 0.89
  • Price/Sales 6.22
  • Price/Cash Flow N/A
  • Price/Book 6.41
Trade CLPT with:

Options Overview Details

View History
  • Implied Volatility 84.40% ( +2.59%)
  • Historical Volatility 36.55%
  • IV Percentile 86%
  • IV Rank 53.50%
  • IV High 152.88% on 03/15/24
  • IV Low 5.61% on 09/19/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 25
  • Volume Avg (30-Day) 19
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 1,323
  • Open Int (30-Day) 2,224

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.19
  • Number of Estimates 2
  • High Estimate -0.17
  • Low Estimate -0.20
  • Prior Year -0.23
  • Growth Rate Est. (year over year) +17.39%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.19 +1.54%
on 04/25/24
6.92 -23.84%
on 03/28/24
-1.47 (-21.81%)
since 03/25/24
3-Month
5.19 +1.54%
on 04/25/24
7.97 -33.88%
on 02/27/24
-1.81 (-25.56%)
since 01/25/24
52-Week
4.05 +30.12%
on 11/10/23
10.80 -51.20%
on 04/28/23
-4.47 (-45.89%)
since 04/25/23

Most Recent Stories

More News
ClearPoint Neuro, Inc. (CLPT) Reports Q3 Loss, Misses Revenue Estimates

ClearPoint Neuro, Inc. (CLPT) delivered earnings and revenue surprises of 21.05% and 6.61%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?...

CLPT : 5.32 (-1.13%)
RPID : 0.9100 (-2.20%)
Shockwave Medical (SWAV) Q3 Earnings and Revenues Beat Estimates

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 35.29% and 4.36%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

SWAV : 329.08 (+0.06%)
CLPT : 5.32 (-1.13%)
ClearPoint Neuro, Inc. (CLPT) Q2 2022 Earnings Call Transcript

CLPT earnings call for the period ending June 30, 2022.

CLPT : 5.32 (-1.13%)
ClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Tops Revenue Estimates

ClearPoint Neuro, Inc. (CLPT) delivered earnings and revenue surprises of 0% and 0.70%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

CLPT : 5.32 (-1.13%)
ARAY : 2.18 (-0.91%)
ClearPoint Neuro Reports Second Quarter 2022 Results

Record Quarterly Revenue Achieved; Company Reaffirms 2022 Revenue Forecast...

CLPT : 5.32 (-1.13%)
Hologic (HOLX) Beats Q3 Earnings and Revenue Estimates

Hologic (HOLX) delivered earnings and revenue surprises of 37.68% and 11.88%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

HOLX : 75.75 (-1.25%)
CLPT : 5.32 (-1.13%)
ClearPoint Neuro Congratulates Partner PTC Therapeutics on Being Granted Marketing Authorization by the European Commission for Upstaza™ - First Disease-Modifying Treatment for AADC Deficiency

First Gene Therapy Approved for Direct Infusion into the Brain will be Administered with ClearPoint’s SmartFlow® Neuro Cannula...

CLPT : 5.32 (-1.13%)
Is Acadia Healthcare (ACHC) Outperforming Other Medical Stocks This Year?

Here is how Acadia Healthcare (ACHC) and ClearPoint Neuro, Inc. (CLPT) have performed compared to their sector so far this year.

ACHC : 73.41 (+3.12%)
CLPT : 5.32 (-1.13%)
ClearPoint Neuro Congratulates Neurona Therapeutics on Dosing of Initial Subject in First Clinical Trial of Regenerative Human Cell Therapy in Adults with Drug-Resistant Focal Epilepsy

SOLANA BEACH, Calif., June 29, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company...

CLPT : 5.32 (-1.13%)
ClearPoint Neuro, Inc. (CLPT) Surges 7.6%: Is This an Indication of Further Gains?

ClearPoint Neuro, Inc. (CLPT) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the...

CLPT : 5.32 (-1.13%)
STIM : 3.54 (-5.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

ClearPoint Neuro Inc. provides neurosurgery platform which includes hardware, software, clinical case and market development services for gene therapy cases principally in the United States and Europe. ClearPoint Neuro Inc., formerly known as MRI Interventions Inc., is based in Irvine, California.

See More

Key Turning Points

3rd Resistance Point 5.72
2nd Resistance Point 5.62
1st Resistance Point 5.47
Last Price 5.32
1st Support Level 5.22
2nd Support Level 5.12
3rd Support Level 4.97

See More

52-Week High 10.80
Fibonacci 61.8% 8.22
Fibonacci 50% 7.43
Fibonacci 38.2% 6.63
Last Price 5.32
52-Week Low 4.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar